Global Male Infertility Diagnosis and Treatment Market 2022-2028

Description

List of Tables

Global Male Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report By Diagnostic Tests (Semen Analysis, Urinalysis, Genetic Testing, Testicular Biopsy, Hormonal Tests, and Others) By Treatment (Drugs, ART Therapy, and Surgery) Forecast Period (2022-2028)

The global male infertility diagnosis and treatment market is anticipated to grow at a significant CAGR of 4% during the forecast period. Erectile dysfunction, varicocele, sperm difficulties, and clogged tubes are all common reasons of male infertility. This, in turn, is driving up demand for male infertility diagnostic tests and treatment options, which help doctors better understand the reason of infertility and, as a result, provide more accurate treatment recommendations. Semen analysis, urinalysis, and hormonal tests are the most common diagnostic tests used to determine the aetiology of male infertility. FSH (follicle-stimulating hormone) and testosterone levels are measured in hormonal testing to detect the overall hormonal system balance and the condition of sperm production. When initial tests indicate that these tests are needed, prolactin and serum LH are two hormonal tests that may be conducted.

The global male infertility diagnosis and treatment market is segmented based on diagnostic tests and treatment. Based on diagnostic tests, the market is classified into semen analysis, urinalysis, genetic testing, testicular biopsy, hormonal tests, and others. Based on treatment, the market is segmented into drugs, ART therapy, and surgery.

The global male infertility diagnosis and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Asia-Pacific regional market is expected to cater to considerable growth during the forecast period owing to significant incidences of infertility coupled with initiatives to promote awareness for diagnosis and treatment of the conditionFor instance, ASPIRE, the Asia Pacific Initiative on Reproduction, was founded in 2001 by Bruno Lunenfeld and P C Wong. The initiative is aimed at improving the knowledge and awareness of ART and infertility-related services that can support to improve the quality of patient care. Additionally, this is intended to develop and advance fertility services in the region and raise awareness and understanding for infertility treatment alternatives among healthcare professionals and the public.

The major companies serving the global male infertility diagnosis and treatment market include Merck KGaA, Halotech DNA SL, PerkinElmer, Inc., Vitrolife AB, and Medical Electronic Systems. among others.

Research Methodology

The market study of the global male infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Male Infertility Diagnosis and Treatment Market Research and Analysis by Diagnostic Tests

2. Global Male Infertility Diagnosis and Treatment Market Research and Analysis by Treatment

The Report Covers

Comprehensive research methodology of the global male infertility diagnosis and treatment market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the male infertility diagnosis and treatment market.
Insights about market determinants that are stimulating the global male infertility diagnosis and treatment market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2017111

Category- Biotechnology

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Male Infertility Diagnosis and Treatment Market
Recovery Scenario of Global Male Infertility Diagnosis and Treatment Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. ByRegion

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Male Infertility Diagnosis and Treatment Market by Diagnostic Tests
- 4.1.1. Semen Analysis
- 4.1.2. Urinalysis
- 4.1.3. Genetic Testing
- 4.1.4. Testicular Biopsy
- 4.1.5. Hormonal Tests
- 4.1.6. Others
4.2. Global Male Infertility Diagnosis and Treatment Market by Treatment
- 4.2.1. Drugs
- 4.2.2. Anti-Retroviral Therapy (ART)
- 4.2.3. Surgery

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. AndroviaLifeSciences
6.2. ASKA Pharmaceutical Co., Ltd.
6.3. AytuBioScience, Inc.
6.4. Bayer AG
6.5. Bristol-Myers Squibb Co.
6.6. Cadila Pharmaceuticals Ltd.
6.7. Centogene AG
6.8. Cook Medical, Inc.
6.9. CooperSurgical Fertility & Genomic Solutions
6.10. Eli Lilly and Co.
6.11. FUJIFILM Irvine Scientific
6.12. Halotech DNA SL
6.13. IntasPharmaceuticals Ltd.
6.14. Merck KGaA
6.15. PerkinElmer, Inc.
6.16. Pfizer, Inc.
6.17. Sanofi S.A.
6.18. SCSA Diagnostics, Inc.
6.19. Vitrolife AB